Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers.

de Munck L, de Bock GH, Otter R, Reiding D, Broeders MJ, Willemse PH, Siesling S.

Br J Cancer. 2016 Aug 23;115(5):517-24. doi: 10.1038/bjc.2016.226. Epub 2016 Aug 4.

2.

Attending the breast screening programme after breast cancer treatment: a population-based study.

de Munck L, Kwast A, Reiding D, de Bock GH, Otter R, Willemse PH, Siesling S.

Cancer Epidemiol. 2013 Dec;37(6):968-72. doi: 10.1016/j.canep.2013.09.003. Epub 2013 Sep 26.

PMID:
24075800
3.

Do screen-detected breast cancers have positive margins less often than clinically detected breast cancers?

de Munck L, Siesling S, Bart J, Menke-Pluijmers MB, Otter R, Willemse PH.

Eur J Cancer Prev. 2013 Sep;22(5):398-403. doi: 10.1097/CEJ.0b013e32835f3b70.

PMID:
23492953
4.

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study.

Reyners AK, de Munck L, Erdkamp FL, Smit WM, Hoekman K, Lalisang RI, de Graaf H, Wymenga AN, Polee M, Hollema H, van Vugt MA, Schaapveld M, Willemse PH; DoCaCel Study Group.

Ann Oncol. 2012 Nov;23(11):2896-902. doi: 10.1093/annonc/mds107. Epub 2012 Jun 11.

5.

Early-stage young breast cancer patients: impact of local treatment on survival.

Bantema-Joppe EJ, de Munck L, Visser O, Willemse PH, Langendijk JA, Siesling S, Maduro JH.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e553-9. doi: 10.1016/j.ijrobp.2011.02.060. Epub 2011 Sep 9.

6.

Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands.

de Munck L, Schaapveld M, Siesling S, Wesseling J, Voogd AC, Tjan-Heijnen VC, Otter R, Willemse PH.

Breast Cancer Res Treat. 2011 Aug;129(1):229-33. doi: 10.1007/s10549-011-1451-0. Epub 2011 Mar 24.

PMID:
21431871
7.

Weekly docetaxel in metastatic breast cancer patients: no superior benefits compared to three-weekly docetaxel.

Schröder CP, de Munck L, Westermann AM, Smit WM, Creemers GJ, de Graaf H, Stouthard JM, van Deijk G, Erjavec Z, van Bochove A, Vader W, Willemse PH.

Eur J Cancer. 2011 Jun;47(9):1355-62. doi: 10.1016/j.ejca.2010.12.018. Epub 2011 Jan 19.

PMID:
21251813
8.

Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.

Leffers N, Lambeck AJ, Gooden MJ, Hoogeboom BN, Wolf R, Hamming IE, Hepkema BG, Willemse PH, Molmans BH, Hollema H, Drijfhout JW, Sluiter WJ, Valentijn AR, Fathers LM, Oostendorp J, van der Zee AG, Melief CJ, van der Burg SH, Daemen T, Nijman HW.

Int J Cancer. 2009 Nov 1;125(9):2104-13. doi: 10.1002/ijc.24597.

9.

Effect of tamoxifen on the endometrium and the menstrual cycle of premenopausal breast cancer patients.

Buijs C, Willemse PH, de Vries EG, Ten Hoor KA, Boezen HM, Hollema H, Mourits MJ.

Int J Gynecol Cancer. 2009 May;19(4):677-81. doi: 10.1111/IGC.0b013e3181a47cbe.

PMID:
19509569
10.

[The limitations of observational research].

van der Zee AG, de Vries EG, Schaapveld M, Willemse PH.

Ned Tijdschr Geneeskd. 2009 Jan 17;153(3):102; author reply 102. Dutch. No abstract available.

PMID:
19235351
11.

Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer.

Engelen MJA, Snel BJ, Schaapveld M, Pras E, de Vries EGE, Gietema JA, van der Zee AGJ, Willemse PHB.

Eur J Cancer. 2009 May;45(7):1193-1200. doi: 10.1016/j.ejca.2009.01.006. Epub 2009 Feb 7.

PMID:
19201598
12.

[Primary surgery by a gynecological oncologist improves the prognosis in patients with ovarian carcinoma].

van der Zee AG, Engelen MJ, Schaapveld M, Karim-Kos HE, de Vries EG, Willemse PH, Otter R.

Ned Tijdschr Geneeskd. 2009 Jan 10;153(1-2):15-9. Dutch. No abstract available.

PMID:
19198207
13.

Sexual function in patients with metastatic midgut carcinoid tumours.

van der Horst-Schrivers AN, van Ieperen E, Wymenga AN, Boezen HM, Weijmar-Schultz WC, Kema IP, Meijer WG, de Herder WW, Willemse PH, Links TP, de Vries EG.

Neuroendocrinology. 2009;89(2):231-6. doi: 10.1159/000178754. Epub 2008 Nov 26.

PMID:
19033719
14.

Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.

Buijs C, Mom CH, Willemse PH, Marike Boezen H, Maurer JM, Wymenga AN, de Jong RS, Nieboer P, de Vries EG, Mourits MJ.

Breast Cancer Res Treat. 2009 Jun;115(3):573-80. doi: 10.1007/s10549-008-0138-7. Epub 2008 Aug 1.

PMID:
18670875
15.

The influence of endocrine treatments for breast cancer on health-related quality of life.

Buijs C, de Vries EG, Mourits MJ, Willemse PH.

Cancer Treat Rev. 2008 Nov;34(7):640-55. doi: 10.1016/j.ctrv.2008.04.001. Epub 2008 Jun 2. Review.

PMID:
18514425
16.

Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.

Schaapveld M, Visser O, Louwman MJ, de Vries EG, Willemse PH, Otter R, van der Graaf WT, Coebergh JW, van Leeuwen FE.

J Clin Oncol. 2008 Mar 10;26(8):1239-46. doi: 10.1200/JCO.2007.11.9081.

PMID:
18323547
17.

Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.

Buijs C, Rodenhuis S, Seynaeve CM, van Hoesel QG, van der Wall E, Smit WJ, Nooij MA, Voest E, Hupperets P, TenVergert EM, van Tinteren H, Willemse PH, Mourits MJ, Aaronson NK, Post WJ, de Vries EG.

J Clin Oncol. 2007 Dec 1;25(34):5403-9.

PMID:
18048822
18.

Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic study.

Joerger M, Huitema AD, Huizing MT, Willemse PH, de Graeff A, Rosing H, Schellens JH, Beijnen JH, Vermorken JB.

Br J Clin Pharmacol. 2007 Nov;64(5):622-33.

19.

Effect of interferon and 5-fluorouracil on serum VEGF levels in neuroendocrine tumours.

Van Der Horst-Schrivers AN, Slot MH, Willemse PH, Kema IP, De Vries EG, Wymenga AN.

Acta Oncol. 2008;47(1):153-5. No abstract available.

PMID:
17851877
20.

Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours.

van der Horst-Schrivers AN, Post WJ, Kema IP, Links TP, Willemse PH, Wymenga AN, de Vries EG.

Eur J Cancer. 2007 Dec;43(18):2651-7. Epub 2007 Sep 6.

PMID:
17825550
21.

Severe disabling tendinopathy caused by anastrazole.

Martens HA, Schröder CP, van der Eerden PJ, Willemse PH, Posthumus MD.

Rheumatology (Oxford). 2007 Oct;46(10):1619-21. Epub 2007 Aug 27. No abstract available.

PMID:
17726034
22.

Beware of amenorrhea during tamoxifen: it may be a wolf in sheep's clothing.

Mourits MJ, de Vries EG, ten Hoor KA, van der Zee AG, Willemse PH.

J Clin Oncol. 2007 Aug 20;25(24):3787-8; author reply 3788-9. No abstract available.

PMID:
17704431
23.

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.

Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, Otter R, Coebergh JW, van Leeuwen FE.

Breast Cancer Res Treat. 2008 Jul;110(1):189-97. Epub 2007 Aug 9.

24.

Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort.

Mom CH, Engelen MJ, Willemse PH, Gietema JA, ten Hoor KA, de Vries EG, van der Zee AG.

Gynecol Oncol. 2007 May;105(2):365-72. Epub 2007 Feb 15.

PMID:
17306349
25.

Distinguishing benign and malignant pelvic masses: the value of different diagnostic methods in everyday clinical practice.

Engelen MJ, Bongaerts AH, Sluiter WJ, de Haan HH, Bogchelman DH, Tenvergert EM, Willemse PH, van der Zee AG.

Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):94-101. Epub 2006 Nov 22.

PMID:
17118522
26.

Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery.

Nijhuis ER, van der Zee AG, in 't Hout BA, Boomgaard JJ, de Hullu JA, Pras E, Hollema H, Aalders JG, Nijman HW, Willemse PH, Mourits MJ.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):699-705. Epub 2006 Aug 14.

PMID:
16904839
27.

The clinical trail of TRAIL.

Duiker EW, Mom CH, de Jong S, Willemse PH, Gietema JA, van der Zee AG, de Vries EG.

Eur J Cancer. 2006 Sep;42(14):2233-40. Epub 2006 Aug 1. Review.

PMID:
16884904
28.

Debulking surgery for ovarian epithelial cancer performed by a gynaecological oncologist improved survival compared with less specialised surgeons.

Engelen MJ, van der Zee AG, de Vries EG, Willemse PH.

Cancer Treat Rev. 2006 Jun;32(4):320-3. Epub 2006 May 16. No abstract available.

PMID:
16707225
29.

[The role of trastuzumab in mammary carcinoma in The Netherlands].

Willemse PH, de Vries EG.

Ned Tijdschr Geneeskd. 2006 Apr 8;150(14):770-5. Dutch.

PMID:
16649393
30.

Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy.

Crijns AP, Duiker EW, de Jong S, Willemse PH, van der Zee AG, de Vries EG.

Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:152-65. Review.

PMID:
16515584
31.

The prognostic effect of the number of histologically examined axillary lymph nodes in breast cancer: stage migration or age association?

Schaapveld M, de Vries EG, van der Graaf WT, Otter R, de Vries J, Willemse PH.

Ann Surg Oncol. 2006 Apr;13(4):465-74. Epub 2006 Feb 20.

PMID:
16485149
32.

Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials.

de Kort SJ, Willemse PH, Habraken JM, de Haes HC, Willems DL, Richel DJ.

Eur J Cancer. 2006 May;42(7):835-45. Epub 2006 Feb 14. Review.

PMID:
16481158
33.

Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.

Engelen MJ, Kos HE, Willemse PH, Aalders JG, de Vries EG, Schaapveld M, Otter R, van der Zee AG.

Cancer. 2006 Feb 1;106(3):589-98.

34.

Hot flushes in breast cancer patients.

Mom CH, Buijs C, Willemse PH, Mourits MJ, de Vries EG.

Crit Rev Oncol Hematol. 2006 Jan;57(1):63-77. Review.

PMID:
16343926
35.

Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.

Russo S, Kema IP, Haagsma EB, Boon JC, Willemse PH, den Boer JA, de Vries EG, Korf J.

Psychosom Med. 2005 Sep-Oct;67(5):773-7.

PMID:
16204437
36.

Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy.

Schaapveld M, de Vries EG, Otter R, de Vries J, Dolsma WV, Willemse PH.

Br J Cancer. 2005 Sep 5;93(5):520-8.

37.

Abdominal angina in patients with a midgut carcinoid, a sign of severe pathology.

deVries H, Wijffels RT, Willemse PH, Verschueren RC, Kema IP, Karrenbeld A, Prins TR, deVries EG.

World J Surg. 2005 Sep;29(9):1139-42.

PMID:
16086212
38.

Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance.

Hougardy BM, Maduro JH, van der Zee AG, Willemse PH, de Jong S, de Vries EG.

Lancet Oncol. 2005 Aug;6(8):589-98. Review.

PMID:
16054570
39.

A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma.

De Vos FY, Bos AM, Schaapveld M, de Swart CA, de Graaf H, van der Zee AG, Boezen HM, de Vries EG, Willemse PH.

Gynecol Oncol. 2005 Apr;97(1):60-7.

PMID:
15790438
40.

A phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancer.

Bos AM, De Vos FY, de Vries EG, Beijnen JH, Rosing H, Mourits MJ, van der Zee AG, Gietema JA, Willemse PH.

Eur J Cancer. 2005 Mar;41(4):539-48. Epub 2005 Jan 11.

PMID:
15737558
41.

Complications of midgut carcinoid tumors and carcinoid syndrome.

van der Horst-Schrivers AN, Wymenga AN, Links TP, Willemse PH, Kema IP, de Vries EG.

Neuroendocrinology. 2004;80 Suppl 1:28-32. Review.

PMID:
15477713
42.

Endothelial cell effects of cytotoxics: balance between desired and unwanted effects.

de Vos FY, Willemse PH, de Vries EG, Gietema JA.

Cancer Treat Rev. 2004 Oct;30(6):495-513. Review.

PMID:
15325031
43.

Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study.

Schaapveld M, de Vries EG, van der Graaf WT, Otter R, Willemse PH.

J Cancer Res Clin Oncol. 2004 Oct;130(10):581-90. Epub 2004 Jul 16.

PMID:
15258754
44.

Variability in axillary lymph node dissection for breast cancer.

Schaapveld M, Otter R, de Vries EG, Fidler V, Grond JA, van der Graaf WT, de Vogel PL, Willemse PH.

J Surg Oncol. 2004 Jul 15;87(1):4-12. Review.

PMID:
15221913
45.

Side effects of therapy: case 2. Tamoxifen and uterine abnormalities.

Buijs C, Willemse PH, Tinga DJ, Hollema H, de Vries EG, Mourits MJ.

J Clin Oncol. 2004 Jun 15;22(12):2505-7. No abstract available.

PMID:
15197214
46.

Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands.

Jansman FG, Postma MJ, van Hartskamp D, Willemse PH, Brouwers JR.

Clin Ther. 2004 Apr;26(4):579-89.

PMID:
15189755
47.

Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation.

Russo S, Boon JC, Kema IP, Willemse PH, den Boer JA, Korf J, de Vries EG.

Psychosom Med. 2004 May-Jun;66(3):422-5.

PMID:
15184706
48.

Successful treatment of metastatic esthesioneuroblastoma.

de Vos FY, Willemse PH, de Vries EG.

Neth J Med. 2003 Dec;61(12):414-6.

49.

Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer.

de Vos FY, Bos AM, Gietema JA, Pras E, Van der Zee AG, de Vries EG, Willemse PH.

Anticancer Res. 2004 Jan-Feb;24(1):345-8.

50.

Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damage.

de Vos FY, Nuver J, Willemse PH, van der Zee AG, Messerschmidt J, Burgerhof JG, de Vries EG, Gietema JA.

Eur J Cancer. 2004 Mar;40(5):696-700.

PMID:
15010070

Supplemental Content

Loading ...
Support Center